$REED
REED'S, INC. Stock $reed

$reed Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000149315223017571 Filed on May 15, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$11.16M	$15.04M	$53.04M
YoY Change	-8.41%	17.67%	6.94%
Cost Of Revenue	$8.459M	$11.59M	$40.93M
YoY Change	-8.55%	13.92%	13.69%
Gross Profit	$2.698M	$3.446M	$12.11M
YoY Change	-7.98%	32.33%	-10.93%
Gross Profit Margin	24.18%	22.91%	22.84%
Selling, General & Admin	$3.156M	$3.562M	$14.50M
YoY Change	-26.59%	-8.9%	-17.73%
% of Gross Profit	116.98%	103.37%	119.75%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$47.00K	$29.00K	$108.0K
YoY Change	88.0%	-178.38%	-24.48%
% of Gross Profit	1.74%	0.84%	0.89%
Operating Expenses	$5.276M	$6.272M	$26.11M
YoY Change	-25.81%	-9.9%	-11.71%
Operating Profit	-$2.578M	-$2.826M	-$14.00M
YoY Change	-38.31%	-35.14%	-12.37%
Interest Expense	$1.779M	-$3.104M	-$5.223M
YoY Change	-322.1%	509.82%	334.89%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$4.357M	-$5.930M	-$19.22M
YoY Change	-12.51%	21.87%	17.17%
Income Tax
% Of Pretax Income
Net Earnings	-$4.357M	-$5.930M	-$19.22M
YoY Change	-12.51%	21.87%	17.2%
Net Earnings / Revenue	-39.05%	-39.43%	-36.24%
Basic Earnings Per Share	-$1.70		-$9.07
Diluted Earnings Per Share	-$1.70	-$2.49	-$9.52
COMMON SHARES
Basic Shares Outstanding	2.602M shares	118.2M shares	2.211M shares
Diluted Shares Outstanding	2.560M shares		2.211M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$467.0K	$533.0K	$533.0K
YoY Change	282.79%	987.76%	987.76%
Cash & Equivalents	$467.0K	$533.0K
Short-Term Investments
Other Short-Term Assets	$601.0K	$1.142M	$1.142M
YoY Change	-61.5%	-23.41%	-23.41%
Inventory	$15.30M	$16.18M	$16.18M
Prepaid Expenses
Receivables	$4.665M	$5.671M	$5.671M
Other Receivables	$777.0K	$1.412M	$1.412M
Total Short-Term Assets	$21.81M	$24.93M	$24.93M
YoY Change	-24.34%	0.92%	0.92%
LONG-TERM ASSETS
Property, Plant & Equipment	$686.0K	$766.0K	$766.0K
YoY Change	-27.02%	-22.78%	-22.78%
Goodwill
YoY Change
Intangibles	$676.0K	$676.0K
YoY Change		0.6%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$1.312M	$1.392M	$1.392M
YoY Change	-16.11%	-13.86%	-13.86%
TOTAL ASSETS
Total Short-Term Assets	$21.81M	$24.93M	$24.93M
Total Long-Term Assets	$1.312M	$1.392M	$1.392M
Total Assets	$23.12M	$26.33M	$26.33M
YoY Change	-23.91%	0.02%	0.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$11.17M	$9.805M	$9.805M
YoY Change	-31.75%	-6.03%	-6.03%
Accrued Expenses	$467.0K	$419.0K	$419.0K
YoY Change	-45.44%	46.5%	-6.26%
Deferred Revenue
YoY Change
Short-Term Debt	$7.593M	$10.97M	$10.97M
YoY Change	1.58%	7.28%	7.28%
Long-Term Debt Due	$5.485M	$2.434M	$2.434M
YoY Change
Total Short-Term Liabilities	$26.76M	$25.66M	$25.66M
YoY Change	5.26%	18.1%	18.1%
LONG-TERM LIABILITIES
Long-Term Debt	$8.526M	$8.092M	$8.092M
YoY Change
Other Long-Term Liabilities	$156.0K	$207.0K	$207.0K
YoY Change	-55.43%	-47.46%	-47.46%
Total Long-Term Liabilities	$8.682M	$8.299M	$8.299M
YoY Change	2380.57%	2006.35%	2006.35%
TOTAL LIABILITIES
Total Short-Term Liabilities	$26.76M	$25.66M	$25.66M
Total Long-Term Liabilities	$8.682M	$8.299M	$8.299M
Total Liabilities	$35.45M	$33.96M	$33.96M
YoY Change	37.52%	53.52%	53.52%
SHAREHOLDERS EQUITY
Retained Earnings	-$127.6M	-$123.2M
YoY Change		19.45%
Common Stock	$0.00	$0.00
YoY Change		-100.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$12.32M	-$7.631M	-$7.631M
YoY Change
Total Liabilities & Shareholders Equity	$23.12M	$26.33M	$26.33M
YoY Change	-23.91%	0.02%	0.02%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$4.357M	-$5.930M	-$19.22M
YoY Change	-12.51%	21.87%	17.2%
Depreciation, Depletion And Amortization	$47.00K	$29.00K	$108.0K
YoY Change	88.0%	-178.38%	-24.48%
Cash From Operating Activities	$1.117M	$1.074M	-$15.43M
YoY Change	-150.61%	-147.02%	-12.26%
INVESTING ACTIVITIES
Capital Expenditures		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	-$2.000K
YoY Change		-100.0%	-77.78%
Cash From Investing Activities		$0.00	-$2.000K
YoY Change		-100.0%	-99.4%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$5.032M
YoY Change			-31.48%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$1.183M	-566.0K	15.92M
YoY Change	-151.89%	-134.81%	-8.4%
NET CHANGE
Cash From Operating Activities	$1.117M	1.074M	-15.43M
Cash From Investing Activities		0.000	-2.000K
Cash From Financing Activities	-$1.183M	-566.0K	15.92M
Net Change In Cash	-$66.00K	508.0K	484.0K
YoY Change		-156.95%	-188.64%
FREE CASH FLOW
Cash From Operating Activities	$1.117M	$1.074M	-$15.43M
Capital Expenditures		$0.00	$0.00
Free Cash Flow	$1.117M	$1.074M	-$15.43M
YoY Change	-150.61%	-152.31%	-10.6%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001140215
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent		usd
CY2021	REED	Provision For Receivable With Former Related Party ProvisionForReceivableWithFormerRelatedParty		usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2021	us-gaap	Dividends Preferred Stock DividendsPreferredStock		usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets		usd
CY2022	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease		usd
CY2022	REED	Gain On Extinguishment Of Ppp Notes Payable GainOnExtinguishmentOfPPPNotesPayable		usd
CY2021	REED	Common Shares Issued As Financing Costs CommonSharesIssuedAsFinancingCosts		usd
CY2021	REED	Provision For Receivable With Former Related Party ProvisionForReceivableWithFormerRelatedParty		usd
CY2021	REED	Accrual Of Interest On Convertible Note AccrualOfInterestOnConvertibleNote		usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		usd
CY2021	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2021	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments		usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
CY2022	REED	Fair Value Of Warrant Recorded To Prepaid Expenses FairValueOfWarrantRecordedToPrepaidExpenses		usd
CY2021	REED	Common Shares Issued For Principal Payment CommonSharesIssuedForPrincipalPayment		usd
CY2021	REED	Common Shares Issued For Interest Payment CommonSharesIssuedForInterestPayment		usd
CY2022	REED	Note Payable Principal Extinguished NotePayablePrincipalExtinguished		usd
CY2021Q4	us-gaap	Secured Debt SecuredDebt		usd
CY2021Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent		usd
CY2021Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet		usd
CY2021Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable		usd
CY2021Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent		usd
CY2021Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable		usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate		pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate		pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2022Q4	REED	Deferred Tax Assets Tax Deferred Finance Costs DeferredTaxAssetsTaxDeferredFinanceCosts		usd
CY2021Q4	REED	Deferred Tax Assets Tax Deferred Finance Costs DeferredTaxAssetsTaxDeferredFinanceCosts		usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2021	REED	Provision For Receivable With Former Related Party ProvisionForReceivableWithFormerRelatedParty		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-32501
CY2022	dei	Entity Registrant Name EntityRegistrantName	REED’S, INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	35-2177773
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	201 Merritt 7
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Norwalk
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	CT
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	06851
CY2022	dei	City Area Code CityAreaCode	(800)
CY2022	dei	Local Phone Number LocalPhoneNumber	997-3337
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	14698231	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2602399	shares
CY2022	dei	Auditor Firm AuditorFirmId	572
CY2022	dei	Auditor Name AuditorName	Weinberg & Company, P.A
CY2022	dei	Auditor Location AuditorLocation	Los Angeles, California
CY2022Q4	us-gaap	Cash Cash	533000	usd
CY2021Q4	us-gaap	Cash Cash	49000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	252000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	215000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5671000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5183000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	16175000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	17049000	usd
CY2022Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	777000	usd
CY2021Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	933000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	939000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1491000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	24095000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	24705000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	787000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	561000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	766000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	992000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	626000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	624000	usd
CY2022Q4	us-gaap	Assets Assets	25487000	usd
CY2021Q4	us-gaap	Assets Assets	26321000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	9805000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	10434000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	233000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	286000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	363000	usd
CY2021Q4	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	0	usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	10974000	usd
CY2021Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	10229000	usd
CY2022Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	2025000	usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	614000	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	414000	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	0	usd
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	2434000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	187000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	161000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	25658000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	21724000	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	562000	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	0	usd
CY2022Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	8092000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	207000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	394000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	33957000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	22118000	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	10
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	10
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	9411	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	9411	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	9411	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	9411	shares
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	94000	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	94000	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	180000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	180000000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2519485	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2519485	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1874866	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1874866	shares
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	114635000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	107246000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-123199000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-103137000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-8470000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	4203000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	25487000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	26321000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	53041000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	49599000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	40929000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	36001000	usd
CY2022	us-gaap	Gross Profit GrossProfit	12112000	usd
CY2021	us-gaap	Gross Profit GrossProfit	13598000	usd
CY2022	REED	Delivery And Handling Expense DeliveryAndHandlingExpense	11603000	usd
CY2021	REED	Delivery And Handling Expense DeliveryAndHandlingExpense	11939000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	7316000	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	9665000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7489000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7965000	usd
CY2022	REED	Provision For Receivable With Former Related Party ProvisionForReceivableWithFormerRelatedParty	538000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	26946000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	29569000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-14834000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-15971000	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	770000	usd
CY2022	us-gaap	Interest Expense InterestExpense	5223000	usd
CY2021	us-gaap	Interest Expense InterestExpense	1201000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-20057000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-16402000	usd
CY2022	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	5000	usd
CY2021	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	5000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-20062000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-16407000	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-9.07
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-8.99
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2211319	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1824688	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	10404000	usd
CY2021	REED	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Vested AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsVested	1684000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	458000	usd
CY2021	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	243000	usd
CY2021	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	15000	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	32000	usd
CY2021	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	472000	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	7327000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-16402000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	4203000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	4203000	usd
CY2022	REED	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Vested AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsVested	701000	usd
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	158000	usd
CY2022	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	2000	usd
CY2022	us-gaap	Dividends Preferred Stock DividendsPreferredStock	5000	usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	37000	usd
CY2022	REED	Stock Issued During Period Value Common Shares Issued For Interest Payment StockIssuedDuringPeriodValueCommonSharesIssuedForInterestPayment	1461000	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	5034000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-20057000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-8470000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-8470000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-20057000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-16402000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	108000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	143000	usd
CY2021	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-67000	usd
CY2021	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	2000	usd
CY2021	REED	Gain On Extinguishment Of Ppp Notes Payable GainOnExtinguishmentOfPPPNotesPayable	770000	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	530000	usd
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	162000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	431000	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	295000	usd
CY2022	REED	Fair Value Of Vested Options FairValueOfVestedOptions	-701000	usd
CY2021	REED	Fair Value Of Vested Options FairValueOfVestedOptions	-1684000	usd
CY2022	REED	Fair Value Of Vested Restricted Shares Granted To Directors And Officers For Services FairValueOfVestedRestrictedSharesGrantedToDirectorsAndOfficersForServices	-158000	usd
CY2021	REED	Fair Value Of Vested Restricted Shares Granted To Directors And Officers For Services FairValueOfVestedRestrictedSharesGrantedToDirectorsAndOfficersForServices	-243000	usd
CY2022	REED	Common Shares Issued As Financing Costs CommonSharesIssuedAsFinancingCosts	37000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	37000	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-19000	usd
CY2022	REED	Provision For Receivable With Former Related Party ProvisionForReceivableWithFormerRelatedParty	538000	usd
CY2022	REED	Increase Decrease In Inventory Write Off IncreaseDecreaseInInventoryWriteOff	-344000	usd
CY2021	REED	Increase Decrease In Inventory Write Off IncreaseDecreaseInInventoryWriteOff	59000	usd
CY2022	REED	Accrual Of Interest On Convertible Note AccrualOfInterestOnConvertibleNote	2313000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	161000	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	115000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	525000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	446000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-531000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5871000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-55000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-322000	usd
CY2022	REED	Increase Decrease In Amortization Of Right Of Use Assets IncreaseDecreaseInAmortizationOfRightOfUseAssets	117000	usd
CY2021	REED	Increase Decrease In Amortization Of Right Of Use Assets IncreaseDecreaseInAmortizationOfRightOfUseAssets	100000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-629000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3688000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-58000	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-609000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-15530000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-17589000	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	2000	usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	9000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	326000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-335000	usd
CY2022	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	54564000	usd
CY2021	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	66234000	usd
CY2022	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	53456000	usd
CY2021	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	56005000	usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	483000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5034000	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	7327000	usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	12430000	usd
CY2022	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	3100000	usd
CY2022	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	1029000	usd
CY2021	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-193000	usd
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2000	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	32000	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2000	usd
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	15000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	16016000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	17378000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	484000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-546000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	49000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	595000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	533000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	49000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	1911000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	430000	usd
CY2022	REED	Dividends On Series Convertible Preferred Stock Value DividendsOnSeriesConvertiblePreferredStockValue	5000	usd
CY2021	REED	Dividends On Series Convertible Preferred Stock Value DividendsOnSeriesConvertiblePreferredStockValue	5000	usd
CY2021	REED	Fair Value Of Warrant Recorded To Prepaid Expenses FairValueOfWarrantRecordedToPrepaidExpenses	458000	usd
CY2022	us-gaap	Stock Issued1 StockIssued1	37000	usd
CY2021	us-gaap	Stock Issued1 StockIssued1	472000	usd
CY2022	REED	Common Shares Issued For Principal Payment CommonSharesIssuedForPrincipalPayment	200000	usd
CY2022	REED	Common Shares Issued For Interest Payment CommonSharesIssuedForInterestPayment	1261000	usd
CY2021	REED	Note Payable Principal Extinguished NotePayablePrincipalExtinguished	770000	usd
CY2022	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_80A_eus-gaap--NatureOfOperations_z4wuWcVxvU8a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1. <span id="xdx_820_zeFso602uoPg">Operations and Liquidity</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reed’s, Inc., (the “Company”) is the owner and maker of Reed’s Craft Ginger Beer, Reed’s Real Ginger Ale, Reed’s Classic and Stormy Mules, and Reed’s Hard Ginger Ales and Virgil’s Handcrafted Sodas. The Company was established in 1989 and is incorporated in the state of Delaware.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective on January 24, 2023, <span id="xdx_90B_eus-gaap--StockholdersEquityReverseStockSplit_c20230122__20230124_zmwTvRt9u8J6" title="Reverse stock split">the Board of Directors and stockholders have approved resolutions authorizing a reverse stock split of the outstanding shares of the Company’s common stock on the basis of 1 share for every 50 shares of common stock</span>. All shares and per share amounts and information presented herein have been retroactively adjusted to reflect the reverse stock split for all periods presented.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Going Concern</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying financial statements, for the year ended December 31, 2022, the Company recorded a net loss of $<span id="xdx_90C_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20220101__20221231_zg5EsrcIqVXe" title="Net income loss">20,057 </span>and used cash in operations of $<span id="xdx_907_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pn3n3_di_c20220101__20221231_z5nbN0jrcire" title="Net cash used in operating activities">15,530</span>. These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year of the date that the financial statements are issued. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022, we had a cash balance of $<span id="xdx_906_eus-gaap--Cash_iI_pn3n3_c20221231_zrlApzKRXUUj" title="Cash">533</span>, with $<span id="xdx_901_eus-gaap--LineOfCreditFacilityCurrentBorrowingCapacity_iI_pn3n3_c20221231_zY8CkocIdUM8" title="Line of credit facility, borrowing capacity">110</span> of current availability, and $<span id="xdx_90F_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pn3n3_c20221231_zBtWaGowFfn6" title="Line of credit facility, additional borrowing capacity">1,663</span> of additional borrowing capacity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Historically, we have financed our operations through public and private sales of common stock, issuance of preferred and common stock, convertible debt instruments, term loans and credit lines from financial institutions, and cash generated from operations. To alleviate these conditions, management is currently evaluating various funding alternatives and may seek to raise additional funds through the issuance of equity, mezzanine or debt securities, through arrangements with strategic partners or through obtaining credit from financial institutions. As we seek additional sources of financing, there can be no assurance that such financing would be available to us on favorable terms or at all. Our ability to obtain additional financing in the debt and equity capital markets is subject to several factors, including market and economic conditions, our performance and investor sentiment with respect to us and our industry.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have also taken decisive action to improve our margins, including fully outsourcing our manufacturing process, streamlining our product portfolio, negotiating improved vendor contracts and restructuring our selling prices.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recent Trends - Market Conditions</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2022, the COVID-19 pandemic continued to impact our operating results and the Company anticipates a residual effect for the balance of the year. In addition, the pandemic could cause reduced demand for our products if, for example, the pandemic results in a recessionary economic environment which negatively affects the consumers who purchase our products. Based on the recent increase in demand for our products, we believe that over the long term, there will continue to be strong demand for our products.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although the U.S. economy continued to grow during the first quarter of 2022, the continuing impact of the COVID-19 pandemic, higher inflation, the actions by the Federal Reserve to address inflation, and rising energy prices create uncertainty about the future economic environment which will continue to evolve and may impact our business in future periods. We have experienced supply chain challenges, including increased lead times, as well as inflation of raw materials, logistics and labor costs due to availability constraints and high demand. Although we regularly monitor companies in our supply chain, and use alternative suppliers when necessary and available, supply chain constraints could cause a disruption in our ability to obtain raw materials required to manufacture our products and adversely affect our operations. We expect the inflationary trends and supply chain pressures to continue throughout 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2022, the Company experienced moderation from elevated freight costs. While the average cost of shipping and handling for the year ended December 31, 2022, was $<span id="xdx_903_ecustom--CarryingCostPropertyAndExplorationRights_pid_uPure_c20220101__20221231_z58doVCK6oE" title="Shipping and handling costs">3.95</span> per case, which is the same as the $<span id="xdx_90D_ecustom--CarryingCostPropertyAndExplorationRights_pid_uPure_c20210101__20211231_zaB19QWxvmS" title="Shipping and handling costs">3.95</span> per case for the year ended December 31, 2021, it was significantly higher during the first half of the year, however, was significantly reduced during the second half of the year. The Company believes these challenges will continue throughout the year. In addition, the Company experienced increases in the pricing of several of its raw materials and delays in procuring several of these items. However, mitigation plans have been implemented to manage this risk. Additionally, the Company was negatively impacted by supply chain challenges impacting our ability to benefit from strong demand for, and increased sales of our product. The disruption caused by labor shortages, significant raw material cost inflation, logistics issues and increased freight costs, and ongoing port congestion, resulted in suppressed margins and net income. The Company anticipates a continued impact throughout 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our ability to operate without significant incremental negative operational impact from the COVID-19 pandemic will in part depend on our ability to protect our employees and protect our supply chain. The Company has endeavored to follow the recommended actions of government and health authorities to protect our employees. Since the inception of the COVID-19 pandemic and through December 31, 2022, we maintained the consistency of our operations during the onset of the COVID-19 pandemic. We will continue to innovate in managing our business, coordinating with our employees and suppliers to do our part to be responsible to our employees and business partners in responding to our customers and suppliers. However, the uncertainty resulting from the pandemic could result in an unforeseen disruption to our workforce and supply chain (for example an inability of a key supplier or transportation supplier to source and transport materials) that could negatively impact our operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have not observed any material impairments of our assets or a significant change in the fair value of our assets due to the COVID-19 pandemic.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nasdaq Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 16, 2021, the Company received a written notice from the Nasdaq Listing Qualifications staff of The Nasdaq Stock Market LLC (“Nasdaq”) that the bid price of the Company’s common stock had closed at less than $1 per share over the previous 30 consecutive business days and, as a result, did not comply with Listing Rule 5550(a)(2) (the “Bid Price Rule”). In accordance with Listing Rule 5810(c)(3)(A), the Company was provided 180 calendar days, or until February 14, 2022, to regain compliance with the Bid Price Rule. The Company did not regain compliance during the compliance period ended February 14, 2022. Accordingly, the Company requested that Nasdaq grant the Company a second 180 calendar day period to regain compliance. On February 15, 2022, the Company was provided an additional 180 calendar day compliance period, or until August 15, 2022, to demonstrate compliance with the Bid Price Rule. The Company did not regain compliance during the compliance period ended August 15, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 16, 2022, the Company received a written notice from Nasdaq indicating that, based upon the Company’s continued non-compliance with the Bid Price Rule, Nasdaq had determined to delist the Company’s securities from Nasdaq unless the Company timely requested a hearing before the Nasdaq Hearings Panel (the “Panel”). The written notice also indicated that the Company was not in compliance with the $<span id="xdx_90B_eus-gaap--CommonEquityTierOneCapitalRequiredForCapitalAdequacy_iI_pn5n6_c20220816_z57ssqJ6AFW2" title="Minimum capital">2.5 </span>million minimum stockholders’ equity requirement for continued listing of the Company’s common stock on Nasdaq as set forth in Nasdaq Listing Rule 5550(b)(1) (the “Minimum Stockholders’ Equity Rule”). The Company timely requested a hearing with the Panel, and after a hearing on September 28, 2022, the Company was given until February 13, 2023, to regain compliance with the Bid Price Rule, and to regain compliance with the Minimum Stockholders’ Equity Rule.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective January 27, 2023, the Company achieved compliance with the Bid Price Rule after effecting a <span id="xdx_90E_eus-gaap--StockholdersEquityReverseStockSplit_c20230126__20230127_zedQfOUu3aZ8" title="Reverse stock split">1:50 reverse split</span> (see Reverse Stock Split below). However, after evaluating options to achieve compliance with the Minimum Stockholders’ Equity Rule, the Company’s board of directors determined not to proceed with a dilutive capital raise. On February 14, 2023, the Company received a written notice that the Nasdaq’s Listing Qualifications staff has determined that the Company’s securities were to be delisted from Nasdaq, and trading in the Company’s common stock was suspended from the Nasdaq Capital Market on February 16, 2023. On February 16, 2023, the Company’s common stock began being quoted for trading on the OTCQX US Market, operated by OTC Markets, Inc. (“OTCQX”), and the Company continues to be a reporting company under the Securities Exchange Act of 1934, as amended.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reverse Stock Split</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At a special meeting of shareholders held on January 24, 2023, the Company’s shareholders granted the Company’s board of directors the discretion to effect a reverse stock split of the common stock through an amendment to the Company’s Certificate of Incorporation, as amended, at a ratio of any ratio not less than <span id="xdx_90B_eus-gaap--StockholdersEquityReverseStockSplit_c20240122__20240124__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zqDNhBKzXsTh" title="Reverse stock split">1-for-6 and not more than 1-for-50</span>, at any time on or prior to January 24, 2024, with the exact ratio to be set at a whole number within this range by the board of directors in its sole discretion. On January 25, 2023, the Company announced that its board of directors approved a <span id="xdx_905_eus-gaap--StockholdersEquityReverseStockSplit_c20230123__20230125_zv23HxvP3WX2" title="Reverse stock split">1-for-50 reverse stock split </span>of the Company’s issued and outstanding shares of common stock, par value $<span id="xdx_909_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20230125_zQb8EKEA0SQ1" title="Common stock par value">0.0001</span> per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The authorized number of shares of common stock were not affected by the reverse stock split. No fractional shares were issued in connection with the reverse stock split, as all fractional shares were rounded up to the next whole share. Accordingly, all share and per share amounts presented herein with respect to common stock have been retroactively adjusted to reflect the above-described reverse stock split for all periods presented.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	the Board of Directors and stockholders have approved resolutions authorizing a reverse stock split of the outstanding shares of the Company’s common stock on the basis of 1 share for every 50 shares of common stock
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-20057000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-15530000	usd
CY2022Q4	us-gaap	Cash Cash	533000	usd
CY2022Q4	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	110000	usd
CY2022Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	1663000	usd
CY2022	REED	Carrying Cost Property And Exploration Rights CarryingCostPropertyAndExplorationRights	3.95	pure
CY2021	REED	Carrying Cost Property And Exploration Rights CarryingCostPropertyAndExplorationRights	3.95	pure
CY2022Q3	us-gaap	Common Equity Tier One Capital Required For Capital Adequacy CommonEquityTierOneCapitalRequiredForCapitalAdequacy	2500000	usd
CY2023Q1	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1:50 reverse split
CY2023Q1	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-50 reverse stock split
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_848_eus-gaap--UseOfEstimates_zhRBTrXzVc67" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_z0H27IJszle4">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Those estimates and assumptions include estimates for reserves of uncollectible accounts receivables, assumptions used in valuing inventories at net realizable value, impairment testing of recorded long-term tangible and intangible assets, the valuation allowance for deferred tax assets, accruals for potential liabilities, assumptions made in valuing stock instruments issued for services, and assumptions used in valuing warrant liabilities, and assumptions used in the determination of the Company’s liquidity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	252000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	215000	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	479000	usd
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	135000	usd
CY2021	REED	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue	226000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Per Share Weighted Average Price Of Shares Purchased ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased	46.00
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	164423	shares
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2022	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	usd
CY2021	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	7348	shares
CY2022	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit	11.69
CY2022	us-gaap	Advertising Expense AdvertisingExpense	668000	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	1418000	usd
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1357945000	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	304206000	shares
CY2022	us-gaap	Convertible Preferred Stock Terms Of Conversion ConvertiblePreferredStockTermsOfConversion	The Series A Convertible Preferred Stock is convertible into Common shares at the rate of 1:0.08
CY2022	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P10Y
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	122000	usd
CY2022Q4	us-gaap	Share Price SharePrice	11.69
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.82	pure
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_841_eus-gaap--ConcentrationRiskCreditRisk_zUqOSzl7KLp7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_zOHNWNtFnumk">Concentrations</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s cash balances on deposit with banks are guaranteed by the Federal Deposit Insurance Corporation (FDIC) up to $<span id="xdx_90D_eus-gaap--CashFDICInsuredAmount_iI_pn3n3_c20221231_z644WMVYyZJc" title="Maximum cash deposit guaranteed by FDIC">250</span>. Generally, the Company’s policy is to minimize borrowing costs by immediately applying cash receipts to borrowings against its credit facility. From time to time, however, the Company may be exposed to risk for the amounts of funds held in bank accounts in excess of the FDIC limit. To minimize the risk, the Company’s policy is to maintain cash balances with high quality financial institutions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Gross sales.</i> During the year ended December 31, 2022, the Company’s largest two customers accounted for <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_ziKTNjX9osT2" title="Concentration risk, percentage">17</span>% and <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_zBzdAyS6NA79" title="Concentration risk, percentage">16</span>% of gross sales, respectively. During the year ended December 31, 2021, the Company’s largest two customers accounted for <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_zbU6Vcd8CHW6" title="Concentration risk, percentage">19</span>% and <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_zFXX0KqgInQe" title="Concentration risk, percentage">11</span>% of gross sales, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounts receivable.</i> As of December 31, 2022, the Company had accounts receivable from two customers which comprised <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zaBpVyOo59Yi" title="Concentration risk, percentage">19</span>% and <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z8NiVITRb9le" title="Concentration risk, percentage">11</span>% of its gross accounts receivable, respectively. As of December 31, 2021, the Company had accounts receivable from one customer which comprised <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zTPfQ3rC0tD4" title="Concentration risk, percentage">18</span>% of its gross accounts receivable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the years ended December 31, 2022, and 2021, the Company utilized six separate co-packers for most its production and bottling of beverage products in the United States. The Company utilizes co-packers to produce <span id="xdx_90F_ecustom--PercentageOfCoPackersProducts_pid_dp_uPure_c20220101__20221231_zQzy0YjWzcg1" title="Percentage of co-packers products">100</span>% of its products. The Company has long-standing relationships with two different co-packers, and in conjunction with the sale of its manufacturing plant we entered into a third co-packing agreement with California Custom Beverage LLC (“CCB”), the purchaser of the plant (see Note 13). CCB is <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__srt--TitleOfIndividualAxis__custom--ChristopherJReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zKPqlyNTf1Jh">100</span>% owned by Chris Reed, founder of the Company and formerly Chief Executive Officer, Chairman, director, and most recently, Chief Innovation Officer. Although there are other packers, a change in co-packers may cause a delay in the production process, which could ultimately affect operating results.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Purchases from vendors.</i> During the year ended December 31, 2022, the Company’s largest vendor accounted for approximately <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__srt--MajorCustomersAxis__custom--VendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_zPxr42nB2Cei" title="Percentage of sale accounted to customer">12</span>% of all purchases. During the year ended December 31, 2021, the Company’s largest two vendors accounted for approximately <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__srt--MajorCustomersAxis__custom--VendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_zGHGiNrbcyD8" title="Percentage of sale accounted to customer">13</span>% and <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__srt--MajorCustomersAxis__custom--VendorTwoMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_z1MFZirUz1y1">10</span>% of all purchases, respectively. No other vendor accounted for more than 10% of the total vendor purchases.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounts payable.</i> As of December 31, 2022, no vendor accounted for more than <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--RangeAxis__srt--MaximumMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zPxnSzKKbn48" title="Concentration risk, percentage">10</span>% of the total accounts payable. As of December 31, 2021, no vendor accounted for more than <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__srt--MajorCustomersAxis__custom--CustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--RangeAxis__srt--MaximumMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z7BU62X1wuSg" title="Concentration risk, percentage">10</span>% of the total accounts payable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022	REED	Percentage Of Co Packers Products PercentageOfCoPackersProducts	1	pure
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	8526000	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	11221000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	7649000	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	5828000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	16175000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	17049000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0289	pure
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	32000	usd
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1260	shares
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1553000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1553000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	787000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	561000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	766000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	992000	usd
CY2022	us-gaap	Depreciation Depreciation	108000	usd
CY2021	us-gaap	Depreciation Depreciation	143000	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	117000	usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	100000	usd
CY2021	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-67000	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2022	us-gaap	Finite Lived Intangible Assets Cost Incurred To Renew Or Extend FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend	2000	usd
CY2021	us-gaap	Finite Lived Intangible Assets Cost Incurred To Renew Or Extend FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend	9000	usd
CY2022Q4	us-gaap	Indefinite Lived Trade Names IndefiniteLivedTradeNames	576000	usd
CY2021Q4	us-gaap	Indefinite Lived Trade Names IndefiniteLivedTradeNames	576000	usd
CY2022Q4	us-gaap	Indefinite Lived Trademarks IndefiniteLivedTrademarks	50000	usd
CY2021Q4	us-gaap	Indefinite Lived Trademarks IndefiniteLivedTrademarks	48000	usd
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	626000	usd
CY2021Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	624000	usd
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	33880	shares
CY2021	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	49.00
CY2021	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit	59.00
CY2021	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P10Y
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	2412000	usd
CY2021Q4	us-gaap	Share Price SharePrice	52.69
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.79	pure
CY2022Q4	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	363000	usd
CY2021Q4	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	0	usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	10974000	usd
CY2021Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	10229000	usd
CY2022Q4	us-gaap	Secured Debt SecuredDebt	10450000	usd
CY2022Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	1052000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	976000	usd
CY2022Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	10526000	usd
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	2434000	usd
CY2022Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	8092000	usd
CY2022Q3	us-gaap	Line Of Credit Facility Unused Capacity Commitment Fee Percentage LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage	0.10	pure
CY2022Q3	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	6000000	usd
CY2022Q3	us-gaap	Debt Issuance Costs Line Of Credit Arrangements Net DebtIssuanceCostsLineOfCreditArrangementsNet	11500000	usd
CY2022Q3	us-gaap	Line Of Credit Facility Expiration Date1 LineOfCreditFacilityExpirationDate1	2025-05-09
CY2022	us-gaap	Lease Cost LeaseCost	178000	usd
CY2021	us-gaap	Lease Cost LeaseCost	179000	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	555000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	161000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	394000	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1260	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0098	pure
CY2022Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	164423	shares
CY2022Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	48.90
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	226000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	221000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	447000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	53000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	394000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	187000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	207000	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	10
CY2022	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	0.05	pure
CY2022Q4	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	10.00
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	9411	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	9411	shares
CY2022	us-gaap	Preferred Stock Conversion Basis PreferredStockConversionBasis	Each share of Preferred Stock can be converted into 0.08 shares of the Company’s common stock
CY2022	REED	Dividends Payable Rate DividendsPayableRate	0.05	pure
CY2022	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	0.08	shares
CY2021	us-gaap	Common Stock Dividends Shares CommonStockDividendsShares	93	shares
CY2021	us-gaap	Preferred Stock Dividend Rate Per Dollar Amount PreferredStockDividendRatePerDollarAmount	5
CY2022	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	5000	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	120000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	180000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	120000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	180000000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2519485	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	180000000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1874866	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	The exercise price of an option granted under the plan cannot be less than 100% of the fair market value per share of common stock on the date of the grant of the option. Options may not be granted under the plan on or after the tenth anniversary of the adoption of the plan. Incentive stock options granted to a person owning more than 10% of the combined voting power of the common stock cannot be exercisable for more than five years
CY2022Q1	REED	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue	150000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Per Share Weighted Average Price Of Shares Purchased ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased	16.00
CY2022	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P7Y6M29D
CY2022Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	80014	shares
CY2022Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	54.32
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.05	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.05	pure
CY2022	REED	Effective Income Tax Rate Reconciliation At Federal And State Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalAndStateIncomeTaxRate	-0.26	pure
CY2021	REED	Effective Income Tax Rate Reconciliation At Federal And State Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalAndStateIncomeTaxRate	-0.26	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.26	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.26	pure
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	21117000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	18573000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	1650000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	1078000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1989000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1764000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	74000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	26000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	125000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	35000	usd
CY2022Q4	REED	Deferred Tax Asset Operating Lease Liability DeferredTaxAssetOperatingLeaseLiability	103000	usd
CY2021Q4	REED	Deferred Tax Asset Operating Lease Liability DeferredTaxAssetOperatingLeaseLiability	145000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	-70000	usd
CY2022Q4	REED	Deferred Tax Asset Reserve For Asset Impairment DeferredTaxAssetReserveForAssetImpairment	58000	usd
CY2021Q4	REED	Deferred Tax Asset Reserve For Asset Impairment DeferredTaxAssetReserveForAssetImpairment	58000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	25046000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	21679000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	24967000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	21570000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	79000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	109000	usd
CY2022Q4	REED	Deferred Tax Asset Operating Lease Rightofuse Asset DeferredTaxAssetOperatingLeaseRightofuseAsset	79000	usd
CY2021Q4	REED	Deferred Tax Asset Operating Lease Rightofuse Asset DeferredTaxAssetOperatingLeaseRightofuseAsset	109000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	79000	usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	109000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	91000000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	80000000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	64000000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	51000000	usd
CY2022	REED	Federal Carryforward Loss Expires FederalCarryforwardLossExpires	2037
CY2022	us-gaap	Operating Loss Carryforwards Limitations On Use OperatingLossCarryforwardsLimitationsOnUse	offset 80% of taxable income in future years
CY2022	REED	Provision For Receivable With Former Related Party ProvisionForReceivableWithFormerRelatedParty	538000	usd
CY2022Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	777000	usd
CY2021Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	933000	usd
CY2022Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	2025000	usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	614000	usd
CY2022Q4	us-gaap	Related Party Transaction Due From To Related Party RelatedPartyTransactionDueFromToRelatedParty	-1248000	usd
CY2021Q4	us-gaap	Related Party Transaction Due From To Related Party RelatedPartyTransactionDueFromToRelatedParty	319000	usd
CY2022	REED	Provision For Receivable With Former Related Party ProvisionForReceivableWithFormerRelatedParty	538000	usd
CY2022Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	2025000	usd

Files In Submission

Name	View Source	Status
0001493152-23-017571-index-headers.html	Edgar Link	pending
0001493152-23-017571-index.html	Edgar Link	pending
0001493152-23-017571.txt	Edgar Link	pending
0001493152-23-017571-xbrl.zip	Edgar Link	pending
ex10-19.htm	Edgar Link	pending
ex10-19_001.jpg	Edgar Link	pending
ex10-19_002.jpg	Edgar Link	pending
ex10-19_003.jpg	Edgar Link	pending
ex10-19_004.jpg	Edgar Link	pending
ex10-20.htm	Edgar Link	pending
ex10-20_001.jpg	Edgar Link	pending
ex10-20_003.jpg	Edgar Link	pending
ex10-20_004.jpg	Edgar Link	pending
ex10-22.htm	Edgar Link	pending
ex10-22_001.jpg	Edgar Link	pending
ex10-22_002.jpg	Edgar Link	pending
ex10-22_003.jpg	Edgar Link	pending
ex10-22_004.jpg	Edgar Link	pending
ex10-22_005.jpg	Edgar Link	pending
ex21.htm	Edgar Link	pending
ex23-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
ex3i.htm	Edgar Link	pending
ex3i_001.jpg	Edgar Link	pending
ex3i_002.jpg	Edgar Link	pending
ex3i_003.jpg	Edgar Link	pending
ex3i_004.jpg	Edgar Link	pending
ex3i_005.jpg	Edgar Link	pending
ex3i_006.jpg	Edgar Link	pending
ex3i_007.jpg	Edgar Link	pending
ex3i_008.jpg	Edgar Link	pending
ex3i_009.jpg	Edgar Link	pending
ex3i_010.jpg	Edgar Link	pending
ex3i_011.jpg	Edgar Link	pending
ex3i_012.jpg	Edgar Link	pending
ex3i_013.jpg	Edgar Link	pending
ex3i_014.jpg	Edgar Link	pending
ex3i_015.jpg	Edgar Link	pending
ex3i_016.jpg	Edgar Link	pending
ex3i_017.jpg	Edgar Link	pending
ex3i_018.jpg	Edgar Link	pending
ex3i_019.jpg	Edgar Link	pending
ex3i_020.jpg	Edgar Link	pending
ex3i_021.jpg	Edgar Link	pending
ex3i_022.jpg	Edgar Link	pending
ex3i_023.jpg	Edgar Link	pending
ex3i_024.jpg	Edgar Link	pending
ex3i_025.jpg	Edgar Link	pending
ex3i_026.jpg	Edgar Link	pending
ex3i_027.jpg	Edgar Link	pending
ex3i_028.jpg	Edgar Link	pending
ex3i_029.jpg	Edgar Link	pending
ex3i_030.jpg	Edgar Link	pending
ex3i_031.jpg	Edgar Link	pending
ex3i_032.jpg	Edgar Link	pending
ex3i_033.jpg	Edgar Link	pending
ex3i_034.jpg	Edgar Link	pending
ex3i_035.jpg	Edgar Link	pending
ex3i_036.jpg	Edgar Link	pending
ex3i_037.jpg	Edgar Link	pending
ex3i_038.jpg	Edgar Link	pending
ex3i_039.jpg	Edgar Link	pending
ex3i_040.jpg	Edgar Link	pending
ex3i_041.jpg	Edgar Link	pending
ex3i_042.jpg	Edgar Link	pending
ex3i_043.jpg	Edgar Link	pending
ex3i_044.jpg	Edgar Link	pending
ex3i_045.jpg	Edgar Link	pending
ex3i_046.jpg	Edgar Link	pending
ex3i_047.jpg	Edgar Link	pending
ex3i_048.jpg	Edgar Link	pending
ex3i_049.jpg	Edgar Link	pending
ex3i_050.jpg	Edgar Link	pending
ex3i_051.jpg	Edgar Link	pending
ex3i_052.jpg	Edgar Link	pending
ex3i_053.jpg	Edgar Link	pending
ex3i_054.jpg	Edgar Link	pending
ex3i_055.jpg	Edgar Link	pending
ex3i_056.jpg	Edgar Link	pending
ex3i_057.jpg	Edgar Link	pending
ex3i_058.jpg	Edgar Link	pending
ex3i_059.jpg	Edgar Link	pending
ex3i_060.jpg	Edgar Link	pending
ex3i_061.jpg	Edgar Link	pending
ex3i_062.jpg	Edgar Link	pending
ex3i_063.jpg	Edgar Link	pending
ex3i_064.jpg	Edgar Link	pending
ex3i_065.jpg	Edgar Link	pending
ex3i_066.jpg	Edgar Link	pending
ex3i_067.jpg	Edgar Link	pending
ex3i_068.jpg	Edgar Link	pending
ex3i_069.jpg	Edgar Link	pending
ex3i_070.jpg	Edgar Link	pending
ex3i_071.jpg	Edgar Link	pending
ex3i_072.jpg	Edgar Link	pending
ex3i_073.jpg	Edgar Link	pending
ex3i_074.jpg	Edgar Link	pending
ex3i_075.jpg	Edgar Link	pending
ex3i_076.jpg	Edgar Link	pending
ex4vi.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
form10-k_htm.xml	Edgar Link	completed
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
reed-20221231.xsd	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
reed-20221231_lab.xml	Edgar Link	unprocessable
reed-20221231_cal.xml	Edgar Link	unprocessable
reed-20221231_def.xml	Edgar Link	unprocessable
reed-20221231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$REED
REED'S, INC. Stock $reed

2023 Q1 Form 10-K Financial Statement

#000149315223017571 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$REED REED'S, INC. Stock $reed

2023 Q1 Form 10-K Financial Statement

#000149315223017571 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$REED
REED'S, INC. Stock $reed